Literature DB >> 10588301

Will pneumococci put quinolones in their place?

J M Legg1, A J Bint.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10588301     DOI: 10.1093/jac/44.4.425

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  5 in total

1.  Macrolide and fluoroquinolone (levofloxacin) resistances among Streptococcus pneumoniae strains: significant trends from the SENTRY Antimicrobial Surveillance Program (North America, 1997-1999).

Authors:  R N Jones; M A Pfaller
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

2.  In vitro and In vivo activities of LB 10827, a new oral cephalosporin, against respiratory pathogens.

Authors:  K S Paek; M Y Kim; C S Lee; H Youn
Journal:  Antimicrob Agents Chemother       Date:  2000-12       Impact factor: 5.191

3.  Activities of newer fluoroquinolones against ciprofloxacin-resistant Streptococcus pneumoniae.

Authors:  E A Coyle; G W Kaatz; M J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

4.  Activities of clinafloxacin, gatifloxacin, gemifloxacin, and trovafloxacin against recent clinical isolates of levofloxacin-resistant Streptococcus pneumoniae.

Authors:  J H Jorgensen; L M Weigel; J M Swenson; C G Whitney; M J Ferraro; F C Tenover
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

5.  Mutant prevention concentrations for single-step fluoroquinolone-resistant mutants of wild-type, efflux-positive, or ParC or GyrA mutation-containing Streptococcus pneumoniae isolates.

Authors:  Heather J Smith; Michael Walters; Tamiko Hisanaga; George G Zhanel; Daryl J Hoban
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.